全文获取类型
收费全文 | 37867篇 |
免费 | 2901篇 |
国内免费 | 121篇 |
专业分类
耳鼻咽喉 | 365篇 |
儿科学 | 1037篇 |
妇产科学 | 690篇 |
基础医学 | 5477篇 |
口腔科学 | 648篇 |
临床医学 | 3968篇 |
内科学 | 8093篇 |
皮肤病学 | 777篇 |
神经病学 | 3881篇 |
特种医学 | 1389篇 |
外国民族医学 | 11篇 |
外科学 | 5263篇 |
综合类 | 437篇 |
一般理论 | 30篇 |
预防医学 | 3093篇 |
眼科学 | 727篇 |
药学 | 2650篇 |
中国医学 | 93篇 |
肿瘤学 | 2260篇 |
出版年
2023年 | 292篇 |
2022年 | 416篇 |
2021年 | 975篇 |
2020年 | 675篇 |
2019年 | 900篇 |
2018年 | 1073篇 |
2017年 | 860篇 |
2016年 | 967篇 |
2015年 | 1018篇 |
2014年 | 1390篇 |
2013年 | 1717篇 |
2012年 | 2696篇 |
2011年 | 2806篇 |
2010年 | 1590篇 |
2009年 | 1315篇 |
2008年 | 2147篇 |
2007年 | 2298篇 |
2006年 | 2192篇 |
2005年 | 1983篇 |
2004年 | 1879篇 |
2003年 | 1577篇 |
2002年 | 1477篇 |
2001年 | 616篇 |
2000年 | 627篇 |
1999年 | 562篇 |
1998年 | 341篇 |
1997年 | 258篇 |
1996年 | 258篇 |
1995年 | 227篇 |
1994年 | 194篇 |
1993年 | 149篇 |
1992年 | 324篇 |
1991年 | 301篇 |
1990年 | 309篇 |
1989年 | 249篇 |
1988年 | 252篇 |
1987年 | 274篇 |
1986年 | 288篇 |
1985年 | 272篇 |
1984年 | 226篇 |
1983年 | 178篇 |
1982年 | 125篇 |
1979年 | 240篇 |
1978年 | 161篇 |
1977年 | 140篇 |
1975年 | 122篇 |
1974年 | 131篇 |
1973年 | 138篇 |
1972年 | 123篇 |
1971年 | 122篇 |
排序方式: 共有10000条查询结果,搜索用时 750 毫秒
101.
102.
The experience with the treatment of malignant histiocytosis has been disappointing. Despite modest treatment success with a combination of cyclophosphamide, Adriamycin (doxorubicin), vincristine and prednisone, the overall prognosis remains poor. There are only a few reports of prolonged complete remissions in pediatric patients. The following report describes two children who have had long-term remission with an aggressive combination chemotherapy program that included intrathecal prophylaxis. The chemotherapeutic regimen described merits further evaluation in a larger number of patients. 相似文献
103.
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. 总被引:12,自引:0,他引:12
Michael T Lin David K Simon Colette H Ahn Lauren M Kim M Flint Beal 《Human molecular genetics》2002,11(2):133-145
The mitochondrial theory of aging proposes that mitochondrial DNA (mtDNA) accumulates mutations with age, and that these mutations contribute to physiological decline in aging and degenerative diseases. Although a great deal of indirect evidence supports this hypothesis, the aggregate burden of mtDNA mutations, particularly point mutations, has not been systematically quantified in aging or neurodegenerative disorders. Therefore, we directly assessed the aggregate burden of brain mtDNA point mutations in 17 subjects with Alzheimer's disease (AD), 10 elderly control subjects and 14 younger control subjects, using a PCR-cloning-sequencing strategy. We found that brain mtDNA from elderly subjects had a higher aggregate burden of mutations than brain mtDNA from younger subjects. The average aggregate mutational burden in elderly subjects was 2 x 10(-4) mutations/bp. The bulk of these mutations were individually rare point mutations, 60% of which changed an amino acid. Control experiments ensure that these results were not due to artifacts arising from PCR error, mistaken identification of nuclear pseudogenes or ex vivo oxidation. Cytochrome oxidase activity correlated negatively with increasing mutational burden. These findings significantly bolster the mitochondrial theory of aging. 相似文献
104.
105.
Heat shock protein hsp72 induction in cortical and striatal astrocytes and neurons following infarction 总被引:3,自引:0,他引:3
F R Sharp D Lowenstein R Simon K Hisanaga 《Journal of cerebral blood flow and metabolism》1991,11(4):621-627
Transient global and transient focal ischemia induced the 72 kDa heat shock protein (hsp72) in neurons in cortex, striatum, and other regions known to be injured during transient ischemia. A novel finding was the induction of hsp72 in islands (cylinders in three dimensions) of cells composed of astrocytes around the perimeter and neurons in the interior. Since histology showed pale staining in these regions, it is proposed that these islands represent areas of focal infarction in the distribution of small cortical and lenticulostriate arteries. Although the factors responsible for hsp72 induction during ischemia and infarction are unknown, these results suggest differences in mechanisms of hsp72 induction in astrocytes compared to neurons. 相似文献
106.
Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. 总被引:1,自引:0,他引:1
Jonathan M Schott Jessica E Simon Nick C Fox Andrew P King M Nadeem Khan Lisa Cipolotti Dominic C Paviour John M Stevens Martin N Rossor 《Movement disorders》2003,18(8):955-958
We describe the pattern and progression of atrophy delineated using fluid registration of serial magnetic resonance imaging scans in a case of multiple system atrophy (MSA). The in vivo findings were consistent with those found at postmortem, including significant supratentorial atrophy concurrent with an unusual degree of cognitive impairment for MSA. 相似文献
107.
108.
109.
110.
Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. 总被引:6,自引:2,他引:4
Dimitrios S Goumenos Sotiris Tsakas Abdel Meguid El Nahas Sotiria Alexandri Simon Oldroyd Pantelitsa Kalliakmani John G Vlachojannis 《Nephrology, dialysis, transplantation》2002,17(12):2145-2152
BACKGROUND: Transforming growth factor-beta(1) (TGF-beta(1)) is the major fibrogenic growth factor implicated in the pathogenesis of renal scarring. Proteinuria is a poor prognostic feature for various types of glomerular disease and its toxic action may be related to the activation of tubular epithelial cells towards increased production of cytokines and chemoattractant peptides. In this work we studied the site of synthesis and expression profile of TGF-beta(1) in the renal tissue of patients with heavy proteinuria and examined the relation of this expression with the urinary excretion of TGF-beta(1). METHODS: Twenty-five patients with heavy proteinuria (8.4+/-3.0 g/24 h) were included in the study. All patients underwent a diagnostic kidney biopsy and were commenced on immunosuppressive therapy with corticosteroids and cyclosporin. The sites of synthesis and expression profile of TGF-beta(1) mRNA and protein in the kidney were examined by in situ hybridization and immunohistochemistry. Urinary and plasma TGF-beta(1) levels were determined by ELISA before the initiation of treatment and 6 months later and compared with those of normal subjects and of patients with IgA nephropathy and normal urinary protein excretion. RESULTS: The site of synthesis and expression of TGF-beta(1) in the renal tissue of patients with heavy proteinuria was mainly localized within the cytoplasm of tubular epithelial cells. Interstitial expression was also present but glomerular TGF-beta(1) expression was found only in patients with mesangial proliferation. Urinary TGF-beta(1) excretion was significantly higher in nephrotic patients compared with normal subjects and with patients with IgA nephropathy and normal urinary protein excretion (783+/-280 vs 310+/-140 and 375+/-90 ng/24 h, respectively; P<0.01). In patients with remission of proteinuria after immunosuppressive therapy, urinary TGF-beta(1) excretion was significantly reduced (from 749+/-290 to 495+/-130 ng/24 h; P<0.01), while in patients with persistent nephrotic syndrome, it remained elevated. CONCLUSIONS: The localization of TGF-beta(1) mRNA and protein within tubular epithelial cells, along with its increased urinary excretion in patients with nephrotic syndrome, suggest the activation of these cells by filtered protein towards increased TGF-beta(1) production. 相似文献